HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takayuki Takeichi Selected Research

ONO-LB 457

12/2009Effect of ONO-4057 and tacrolimus on ischemia-reperfusion injury of the liver.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takayuki Takeichi Research Topics

Disease

3Pathologic Constriction (Stenosis)
11/2005 - 04/2005
2Gastroesophageal Reflux (GERD)
06/2019 - 01/2019
2Ischemia
01/2017 - 12/2009
2Polyneuropathies (Polyneuropathy)
08/2013 - 06/2012
2Hepatic Encephalopathy
06/2013 - 08/2002
2Hepatolenticular Degeneration (Wilson's Disease)
06/2013 - 05/2007
2Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
04/2013 - 10/2005
2Neoplasms (Cancer)
05/2012 - 05/2010
2Brain Diseases (Brain Disorder)
10/2005 - 08/2002
2Coma (Comas)
10/2005 - 08/2002
1Necrosis
01/2017
1Shock
01/2017
1Wounds and Injuries (Trauma)
01/2017
1Inflammation (Inflammations)
01/2017
1Peritonitis
11/2013
1Abdominal Pain (Pain, Abdominal)
11/2013
1Hepatocellular Carcinoma (Hepatoma)
11/2013
1Nausea
11/2013
1Liver Diseases (Liver Disease)
08/2013
1Neutropenia
06/2013
1Hepatitis C
04/2013
1Amyloid Neuropathies (Amyloid Neuropathy)
06/2012
1Liver Neoplasms (Liver Cancer)
05/2012
1Cholangitis
03/2012
1Thrombocytopenia (Thrombopenia)
09/2011
1Rhabdomyosarcoma
06/2011
1Focal Nodular Hyperplasia
06/2011
1Angiomyolipoma
06/2011
1Reperfusion Injury
12/2009
1Biliary Atresia
11/2009
1Incisional Hernia
03/2009
1Arteriovenous Malformations (Arteriovenous Malformation)
01/2009
1Liver Failure
01/2009
1Liver Cirrhosis (Hepatic Cirrhosis)
05/2007
1Diaphragmatic Hernia
05/2007
1Chronic Kidney Failure (Chronic Renal Failure)
10/2005
1Acute Liver Failure (Fulminant Hepatic Failure)
08/2002

Drug/Important Bio-Agent (IBA)

2Esomeprazole (Nexium)FDA Link
06/2019 - 01/2019
21- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
06/2019 - 01/2019
1PotassiumIBA
01/2019
1AcidsIBA
01/2019
1Proton Pump InhibitorsIBA
01/2019
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
01/2017
1ChemokinesIBA
01/2017
1CytokinesIBA
01/2017
1Transaminases (Aminotransferases)IBA
01/2017
1TamoxifenFDA LinkGeneric
11/2013
1Penicillamine (Cuprimine)FDA Link
06/2013
1Chelating AgentsIBA
06/2013
1RNA (Ribonucleic Acid)IBA
04/2013
1Amyloid (Amyloid Fibrils)IBA
06/2012
1IntegrinsIBA
05/2012
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
05/2012
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2012
1enhanced green fluorescent proteinIBA
05/2010
1Leukotriene B4IBA
12/2009
1ONO-LB 457IBA
12/2009
1Tacrolimus (Prograf)FDA LinkGeneric
12/2009
1AmmoniaIBA
10/2005

Therapy/Procedure

14Liver Transplantation
11/2013 - 08/2002
6Transplantation
01/2017 - 08/2005
2Aftercare (After-Treatment)
01/2019 - 06/2011
1Length of Stay
08/2013
1Blood Component Removal (Apheresis)
06/2013
1Therapeutics
06/2013
1Operative Surgical Procedures
06/2012
1Lasers (Laser)
05/2010
1Renal Dialysis (Hemodialysis)
10/2005